$LFVN
Lifevantage Corp Stock $lfvn

$lfvn Overview Financials Valuation SEC Filings Company Website

2019 Q2 Form 10-Q Financial Statement

#000084914619000042 Filed on May 01, 2019

Income Statement

Concept	2019 Q2	2019 Q1	2018 Q4
Revenue	$56.17M	$56.01M	$58.17M
YoY Change	3.95%	10.78%	17.55%
Cost Of Revenue	$9.710M	$9.270M	$9.794M
YoY Change	20.32%	3.91%	7.43%
Gross Profit	$46.46M	$46.74M	$48.37M
YoY Change	1.08%	12.25%	19.84%
Gross Profit Margin	82.71%	83.45%	83.16%
Selling, General & Admin	$40.79M	$17.30M	$19.62M
YoY Change	-2.09%	15.13%	33.96%
% of Gross Profit	87.8%	37.0%	40.55%
Research & Development		$100.0K	$500.0K
YoY Change		-66.67%	66.67%
% of Gross Profit		0.21%	1.03%
Depreciation & Amortization	$540.0K	$480.0K	$440.0K
YoY Change	38.46%	77.78%	37.5%
% of Gross Profit	1.16%	1.03%	0.91%
Operating Expenses	$40.79M	$44.50M	$47.79M
YoY Change	-2.09%	13.11%	25.64%
Operating Profit	$5.670M	$2.241M	$581.0K
YoY Change	31.8%	-2.48%	-75.03%
Interest Expense	-$360.0K	$72.00K	$100.0K
YoY Change	300.0%	-21.74%	-2.91%
% of Operating Profit	-6.35%	3.21%	17.21%
Other Income/Expense, Net	$190.0K	-$83.00K	-$172.0K
YoY Change	-190.48%	27.69%	-36.76%
Pretax Income	$5.500M	$2.158M	$409.0K
YoY Change	37.5%	-3.36%	-80.1%
Income Tax	$1.590M	$376.0K	-$420.0K
% Of Pretax Income	28.91%	17.42%	-102.69%
Net Earnings	$3.907M	$1.782M	$829.0K
YoY Change	30.58%	8.99%	161.51%
Net Earnings / Revenue	6.96%	3.18%	1.43%
Basic Earnings Per Share	$0.27	$0.13	$0.06
Diluted Earnings Per Share	$0.26	$0.12	$0.06
COMMON SHARES
Basic Shares Outstanding	14.34M shares	14.17M shares	13.94M shares
Diluted Shares Outstanding		15.29M shares	14.96M shares

Balance Sheet

Concept	2019 Q2	2019 Q1	2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$18.82M	$15.91M	$18.99M
YoY Change	13.03%	14.05%	48.48%
Cash & Equivalents	$18.82M	$15.91M	$18.99M
Short-Term Investments
Other Short-Term Assets	$7.310M	$7.640M	$6.130M
YoY Change	19.06%	-2.68%	51.36%
Inventory	$13.75M	$14.49M	$13.30M
Prepaid Expenses
Receivables	$2.066M	$1.916M	$2.376M
Other Receivables	$1.230M	$2.710M	$2.860M
Total Short-Term Assets	$43.19M	$42.68M	$43.66M
YoY Change	10.91%	8.79%	23.7%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.131M	$6.818M	$5.848M
YoY Change	8.26%	20.46%	25.93%
Goodwill
YoY Change
Intangibles	$983.0K	$1.016M	$1.049M
YoY Change	-11.84%	-11.5%	-11.18%
Long-Term Investments
YoY Change
Other Assets	$1.278M	$1.245M	$1.255M
YoY Change	2.49%	-4.16%	9.89%
Total Long-Term Assets	$12.09M	$11.43M	$10.44M
YoY Change	-0.98%	-2.32%	0.69%
TOTAL ASSETS
Total Short-Term Assets	$43.19M	$42.68M	$43.66M
Total Long-Term Assets	$12.09M	$11.43M	$10.44M
Total Assets	$55.27M	$54.11M	$54.09M
YoY Change	8.08%	6.24%	18.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.180M	$5.065M	$4.108M
YoY Change	35.85%	9.42%	25.67%
Accrued Expenses	$11.05M	$20.29M	$22.49M
YoY Change	6.21%	6.85%	31.91%
Deferred Revenue	$998.0K
YoY Change	-9.85%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.454M	$1.939M	$2.000M
YoY Change	-27.3%	-3.05%	0.0%
Total Short-Term Liabilities	$26.20M	$27.48M	$28.76M
YoY Change	10.04%	6.96%	26.55%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$2.427M
YoY Change	-100.0%	-100.0%	-45.55%
Other Long-Term Liabilities	$1.879M	$1.881M	$1.885M
YoY Change	-5.01%	-4.61%	-4.12%
Total Long-Term Liabilities	$1.879M	$1.881M	$4.312M
YoY Change	-65.14%	-68.32%	-32.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.20M	$27.48M	$28.76M
Total Long-Term Liabilities	$1.879M	$1.881M	$4.312M
Total Liabilities	$28.07M	$29.36M	$33.08M
YoY Change	-3.84%	-7.17%	13.46%
SHAREHOLDERS EQUITY
Retained Earnings	-$99.96M	-$100.9M	-$102.5M
YoY Change	-2.7%	-3.63%	-3.41%
Common Stock	$127.1M	$125.7M	$123.5M
YoY Change	1.95%	1.4%	0.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$27.20M	$24.75M	$21.02M
YoY Change
Total Liabilities & Shareholders Equity	$55.27M	$54.11M	$54.09M
YoY Change	8.08%	6.24%	18.48%

Cashflow Statement

Concept	2019 Q2	2019 Q1	2018 Q4
OPERATING ACTIVITIES
Net Income	$3.907M	$1.782M	$829.0K
YoY Change	30.58%	8.99%	161.51%
Depreciation, Depletion And Amortization	$540.0K	$480.0K	$440.0K
YoY Change	38.46%	77.78%	37.5%
Cash From Operating Activities	$6.980M	$3.870M	$4.570M
YoY Change	27.61%	24.44%	109.63%
INVESTING ACTIVITIES
Capital Expenditures	-$820.0K	-$1.420M	-$180.0K
YoY Change	-35.94%	13.6%	-80.85%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$600.0K
YoY Change
Cash From Investing Activities	-$820.0K	-$1.420M	-$780.0K
YoY Change	-35.94%	13.6%	-17.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.310M	-5.490M	-1.990M
YoY Change	116.34%	662.5%	165.33%
NET CHANGE
Cash From Operating Activities	6.980M	3.870M	4.570M
Cash From Investing Activities	-820.0K	-1.420M	-780.0K
Cash From Financing Activities	-3.310M	-5.490M	-1.990M
Net Change In Cash	2.850M	-3.040M	1.800M
YoY Change	7.14%	-366.67%	267.35%
FREE CASH FLOW
Cash From Operating Activities	$6.980M	$3.870M	$4.570M
Capital Expenditures	-$820.0K	-$1.420M	-$180.0K
Free Cash Flow	$7.800M	$5.290M	$4.750M
YoY Change	15.56%	21.33%	52.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	lfvn	Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities	200000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	100000	USD
CY2019Q1	lfvn	Revenue Recognition Sale Returns Acceptable Percentage From Terminated Distributors RevenueRecognitionSaleReturnsAcceptablePercentageFromTerminatedDistributors	0.3
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000849146
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14340159	shares
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	Lifevantage Corp
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Trading Symbol TradingSymbol	LFVN
CY2018Q1	lfvn	Commission And Incentives CommissionAndIncentives	24320000	USD
	lfvn	Commission And Incentives CommissionAndIncentives	71124000	USD
CY2019Q1	lfvn	Commission And Incentives CommissionAndIncentives	27205000	USD
CY2018Q1	lfvn	Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities	600000	USD
	lfvn	Commission And Incentives CommissionAndIncentives	83166000	USD
	lfvn	Money Back Guarantee Period MoneyBackGuaranteePeriod	P30D
	lfvn	Notes Receivable Related Party Interest Rate NotesReceivableRelatedPartyInterestRate	0.08
CY2019Q1	lfvn	Notes Receivable Related Party Maximum Commitment NotesReceivableRelatedPartyMaximumCommitment	2000000	USD
	lfvn	Number Of Geographic Segments NumberOfGeographicSegments	2	Segment
CY2019Q1	lfvn	Percent Of Restocking Fee PercentOfRestockingFee	0.1
CY2019Q1	lfvn	Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities	100000	USD
	lfvn	Sharebased Compensation Arrangementby Sharebased Payment Award Increase Decreaseof Sharebased Liabilities SharebasedCompensationArrangementbySharebasedPaymentAwardIncreaseDecreaseofSharebasedLiabilities	500000	USD
CY2018Q2	lfvn	Stockholders Equity Attributableto Parent Adjusted Balance StockholdersEquityAttributabletoParentAdjustedBalance	21944000	USD
CY2018Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3813000	USD
CY2019Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	5065000	USD
CY2018Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2067000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1916000	USD
CY2018Q2	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	7546000	USD
CY2019Q1	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	8336000	USD
CY2018Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	14000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-32000	USD
CY2018Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	124663000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	125695000	USD
CY2018Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2974000	USD
CY2019Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	193000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1300000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	2300000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	1000000	USD
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	3600000	USD
CY2018Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	629000	USD
CY2018Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	999000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2006000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	15000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	23000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	10000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2018Q2	us-gaap	Assets Assets	51142000	USD
CY2019Q1	us-gaap	Assets Assets	54105000	USD
CY2018Q2	us-gaap	Assets Current AssetsCurrent	38938000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	42677000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11458000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13952000	USD
CY2018Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16652000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15913000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2494000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-739000	USD
CY2018Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2018Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14073000	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14328000	shares
CY2018Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14073000	shares
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14328000	shares
CY2018Q2	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1732000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2932000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1740000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3476000	USD
CY2018Q2	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	400000	USD
CY2019Q1	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	300000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	8921000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	26778000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9270000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	28263000	USD
CY2018Q2	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	-3000	USD
CY2018Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3500000	USD
CY2019Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	0	USD
CY2018Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	88000	USD
CY2019Q1	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	0	USD
CY2019Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	2000000	USD
CY2018Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	3255000	USD
CY2019Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2349000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	493000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	906000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	942000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1356000	USD
CY2018Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-100000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-200000	USD
CY2019Q1	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-100000	USD
	us-gaap	Derivative Instruments Not Designated As Hedging Instruments Gain Loss Net DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet	-200000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.20
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.13
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.20
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.12
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.24
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	46000	USD
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-47000	USD
CY2018Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	100000	USD
CY2019Q1	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-44000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-100000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	41641000	USD
	us-gaap	Gross Profit GrossProfit	122393000	USD
CY2019Q1	us-gaap	Gross Profit GrossProfit	46742000	USD
	us-gaap	Gross Profit GrossProfit	141525000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2233000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	5546000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2158000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3732000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	598000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2800000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2777000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	376000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	210000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	200000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1793000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	1195000	USD
CY2018Q2	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	451000	USD
CY2019Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2718000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-230000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1266000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-42000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-144000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-143000	USD
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	149000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3311000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2161000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-633000	USD
	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	2267000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-985000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	878000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-104000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-7000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-588000	USD
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-416000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2668000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-692000	USD
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	172000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	161000	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1121000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	951000	shares
CY2018Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1115000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1016000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	92000	USD
	us-gaap	Interest Expense InterestExpense	357000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	72000	USD
	us-gaap	Interest Expense InterestExpense	282000	USD
	us-gaap	Interest Paid Net InterestPaidNet	216000	USD
	us-gaap	Interest Paid Net InterestPaidNet	263000	USD
CY2018Q2	us-gaap	Inventory Net InventoryNet	13627000	USD
CY2018Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7859000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	10237000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	14490000	USD
CY2018Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	5768000	USD
CY2019Q1	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	4253000	USD
CY2018Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1400000	USD
CY2019Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	500000	USD
CY2018Q2	us-gaap	Liabilities Liabilities	29195000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	29359000	USD
CY2018Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	51142000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	54105000	USD
CY2018Q2	us-gaap	Liabilities Current LiabilitiesCurrent	23805000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	27478000	USD
CY2018Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	2000000	USD
CY2019Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1939000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	1500000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	500000	USD
CY2018Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	3412000	USD
CY2019Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1970000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7808000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3367000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3689000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7785000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10805000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	1635000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2769000	USD
CY2018Q3	us-gaap	Net Income Loss NetIncomeLoss	911000	USD
CY2018Q4	us-gaap	Net Income Loss NetIncomeLoss	829000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	1782000	USD
	us-gaap	Net Income Loss NetIncomeLoss	3522000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-65000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-477000	USD
CY2019Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-83000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-414000	USD
CY2019Q1	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	2100000	USD
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	39343000	USD
	us-gaap	Operating Expenses OperatingExpenses	116370000	USD
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	44501000	USD
	us-gaap	Operating Expenses OperatingExpenses	137379000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2298000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	6023000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	2241000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-46000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	4146000	USD
	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	0	USD
	us-gaap	Origination Of Notes Receivable From Related Parties OriginationOfNotesReceivableFromRelatedParties	2000000	USD
CY2018Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	10407000	USD
CY2019Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11950000	USD
CY2018Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1247000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1245000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	97000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	163000	USD
CY2018Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-125000	USD
CY2018Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	121000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-42000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-46000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	97000	USD
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	163000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-42000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1881000	USD
CY2018Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1978000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	27000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-120000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-11000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-132000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	500000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1706000	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	0	USD
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3167000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3367000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1689000	USD
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2019Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6141000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7640000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	30000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	565000	USD
CY2018Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6587000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6818000	USD
CY2018Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1500000	USD
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	3500000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	300000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	800000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	100000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1000000	USD
CY2018Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-102731000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-100918000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	50562000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	149171000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	56012000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	169788000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	15023000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	45246000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	17296000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	54213000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2110000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	4136000	USD
CY2018Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	172000	USD
CY2018Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	381000	USD
CY2017Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	5000000	USD
CY2019Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	15000000	USD
CY2019Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	11800000	USD
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	100000	shares
CY2018Q4	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1500000	USD
CY2019Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	206000	USD
CY2018Q2	us-gaap	Stockholders Equity StockholdersEquity	21947000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	23531000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	21018000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	24746000	USD
CY2018Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	39000	USD
CY2019Q1	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	188000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14178000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14136000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15286000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14978000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14006000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	13975000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14165000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14027000	shares
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Concentration of Credit Risk</font></div><div style="line-height:120%;padding-bottom:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Accounting guidance for financial instruments requires disclosure of significant concentrations of credit risk regardless of the degree of such risk. Financial instruments with significant credit risk include cash and investments.</font></div></div>
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Commitments and Contingencies</font></div><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</font></div><div style="line-height:120%;padding-bottom:10px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company accounts for contingent liabilities in accordance with Accounting Standards Codification ("ASC") Topic 450, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Contingencies</font><font style="font-family:inherit;font-size:10pt;">. This guidance requires management to assess potential contingent liabilities that may exist as of the date of the financial statements to determine the probability and amount of loss that may have occurred, which inherently involves an exercise of judgment. If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed. For loss contingencies considered remote, no accrual or disclosures are generally made. Management has assessed potential contingent liabilities as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2019</font><font style="font-family:inherit;font-size:10pt;">, and based on the assessment, there are no probable loss contingencies requiring accrual or disclosures within its financial statements.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Legal Accruals</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In addition to commitments and obligations in the ordinary course of business, from time to time, the Company is subject to various claims, pending and potential legal actions, investigations relating to governmental laws and regulations and other matters arising out of the normal conduct of its business. Management assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in the consolidated financial statements. An estimated loss contingency is accrued in the consolidated financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Because evaluating legal claims and litigation results are inherently unpredictable and unfavorable results could occur, assessing contingencies is highly subjective and requires judgments about future events. When evaluating contingencies, management may be unable to provide a meaningful estimate due to a number of factors, including the procedural status of the matter in question, the presence of complex or novel legal theories, and/or the ongoing discovery and development of information important to the matters. In addition, damage amounts claimed or asserted against the Company may be unsupported, exaggerated or unrelated to possible outcomes, and as such are not meaningful indicators of a potential liability. Management regularly reviews contingencies to determine the adequacy of financial statement accruals and related disclosures. The amount of ultimate loss may differ from these estimates. It is possible that cash flows or results of operations could be materially affected in any particular period by the unfavorable resolution of one or more of these contingencies. Whether any losses finally determined in any claim, action, investigation or proceeding could reasonably have a material effect on the Company's business, financial condition, results of operations or cash flows will depend on a number of variables, including: the timing and amount of such losses; the structure and type of any remedies; the significance of the impact any such losses, damages or remedies may have on the consolidated financial statements; and the unique facts and circumstances of the particular matter that may give rise to additional factors.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Class Action Lawsuit (</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Smith v. LifeVantage Corp</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;">.): </font><font style="font-family:inherit;font-size:10pt;">On January 24, 2018, a purported class action was filed in the United States District Court for the District of Connecticut, entitled </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Smith v. LifeVantage Corp</font><font style="font-family:inherit;font-size:10pt;">., Case No. 3:18-cv-a35 (D. Connecticut filed Jan. 24, 2018). In this action, plaintiff alleged that the Company, its Chief Executive Officer, Chief Sales Officer and Chief Marketing Officer operated a pyramid scheme in violation of a variety of federal and state statutes, including RICO and the Connecticut Unfair Trade Practices Act. On April 16, 2018, the Company filed motions with the court to dismiss the complaint against LifeVantage, dismiss the complaint against the Company's executives, transfer the venue of the case from the State of Connecticut to the State of Utah, and contest class certification. On July 23, 2018, the parties filed a stipulation with the Court agreeing to transfer the case to the Federal District Court for Utah. On September 20, 2018, Plaintiffs filed an amended complaint in Utah. As per the parties stipulated agreement, plaintiff's amended complaint dropped the RICO and Connecticut state law claims and removed the Company's Chief Sales Officer and Chief Marketing Officer as individual defendants (the Chief Executive Officer remains a defendant in the case). However, the amended complaint adds a new antitrust claim, alleging that the Company fraudulently obtained patents for its products and is attempting to use those patents in an anti-competitive manner. LifeVantage filed a Motion to Dismiss the amended complaint on November 5, 2018, Plaintiffs filed a response to LifeVantage’s Motion to Dismiss on December 17, 2018, and LifeVantage filed a reply brief on January 10, 2019. With the matter now being fully briefed, the Court can issue a ruling based on the briefs submitted by the parties or schedule a hearing for oral argument before entering a decision on the motion. The Company has not established a loss contingency accrual for this lawsuit as it believes liability is not probable or estimable, and the Company plans to vigorously defend against this lawsuit. Nonetheless, an unfavorable resolution of this matter could have a material adverse effect on the Company's business, results of operations or financial condition.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:left;text-indent:24px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Matters.</font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"> </font><font style="font-family:inherit;font-size:10pt;">In addition to the matters described above, the Company also may become involved in other litigation and regulatory matters incidental to its business and the matters disclosed in this quarterly report on Form 10-Q, including, but not limited to, product liability claims, regulatory actions, employment matters and commercial disputes. The Company intends to defend itself in any such matters and does not currently believe that the outcome of any such matters will have a material adverse effect on the Company's business, financial condition, results of operations and cash flows.</font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company prepares the condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America (GAAP). In preparing these statements, the Company is required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, the Company reviews its estimates, including those related to inventory valuation and obsolescence, sales returns, income taxes and tax valuation reserves, transfer pricing methodology and positions, impairment of receivables, share-based compensation, and loss contingencies.</font></div></div>

Files In Submission

Name	View Source	Status
0000849146-19-000042-index-headers.html	Edgar Link	pending
0000849146-19-000042-index.html	Edgar Link	pending
0000849146-19-000042.txt	Edgar Link	pending
0000849146-19-000042-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
lfvn-20190331.xml	Edgar Link	completed
lfvn-20190331.xsd	Edgar Link	pending
lfvn-20190331_cal.xml	Edgar Link	unprocessable
lfvn-20190331_def.xml	Edgar Link	unprocessable
lfvn-20190331_lab.xml	Edgar Link	unprocessable
lfvn-20190331_pre.xml	Edgar Link	unprocessable
lfvn_033119x10q.htm	Edgar Link	pending
lfvn_033119xex311.htm	Edgar Link	pending
lfvn_033119xex312.htm	Edgar Link	pending
lfvn_033119xex321.htm	Edgar Link	pending
lfvn_033119xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFVN
Lifevantage Corp Stock $lfvn

2019 Q2 Form 10-Q Financial Statement

#000084914619000042 Filed on May 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFVN Lifevantage Corp Stock $lfvn

2019 Q2 Form 10-Q Financial Statement

#000084914619000042 Filed on May 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFVN
Lifevantage Corp Stock $lfvn